25 years of translating scientific discoveriesinto affordable, globally accessible
public health solutions
Visit the IAVI 25 website
new approaches to developing vaccines and antibodies for HIV, TB, emerging infectious diseases, and neglected diseases.
translational and clinical research through our laboratories in the U.S., India, and the U.K.
in-country for researching vaccine candidates while strengthening local public health and scientific expertise.
with industry and enlist biopharma product development skills to develop innovative products tailored to target populations.
IAVI’s resources with other innovators to help the global health community as a whole succeed.